Thanks for both of your posts Abew. Good to see they still expect full accrual in April.
Regarding the presentation at the 18 and 21 minute marks, I want to believe. But, they used MMSE and ADAS-Cog11 instead the more rigorous ADAS-Cog13...AND the placebo group in the AD study also showed improvement...so while I am hopeful, I remain skeptical (which is appropriate IMO.) Graph at the 21 minute mark compares a tiny sample set with significant extrapolation to studies with thousands of patients.
As I wrote, I am hopeful - will be totally fired up if B is successful in its trials. Am not buying a private island yet.
Market Data 
Markets 
AI
